Katie Quinn

Senior Medical Science Liaison @Pfizer

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Dec 2023 — Present

Senior Medical Science Liaison @Pfizer

View department →

Boston, MA, US

Seagen was acquired by Pfizer in December 2023.

EDUCATION

2008 — 2010

Boston College

Masters, Family Nurse Practitioner

2022 — 2025

Boston College

Doctor of Nursing Practice

2001 — 2005

University of Rochester

BA, Biology and Spanish

ABOUT KATIE QUINN

Passionate and accomplished biopharma/medical affairs professional with experience supporting ADCs and an immunooncology focused pipeline comprised of ADCs, bispecifics, and monoclonal antibodies. Plays key role throughout the lifecycle of products including clinical development, pre-launch, launch and post-launch. Proven ability in establishing and maintaining KOL relationships, and in providing proprietary therapeutic area information and the gathering of insights to help inform medical strategy. Over a decade of experience as an oncology nurse practitioner with a robust experience in solid tumors (breast, GI, GU, GYN, lung) and hematology, as well as involvement in clinical trials.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Katie Quinn — Senior Medical Science Liaison at Pfizer in Boston, MA, US | Unifers